Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Last updated: April 1, 2025
Sponsor: Memorial Sloan Kettering Cancer Center
Overall Status: Active - Recruiting

Phase

2

Condition

Premenstrual Syndrome

Cancer

Treatment

Acupuncture

No Acupuncture

Clinical Study ID

NCT06915116
25-020
  • Ages 18-39
  • Female

Study Summary

The purpose of this study is to find out whether it is practical (feasible) to use acupuncture to treat period loss (amenorrhea) caused by chemotherapy treatment in people with cancer. The researchers will look at how many participants enroll and complete the study. The researchers will also study how treatment with acupuncture affects the amount of time for the menstrual cycle to return and symptoms and quality of life related to amenorrhea.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • English speaking women under the age of 40, with a history of stage I, II, or IIIcancer at the age of 18-39

  • Premenopausal status with regular menstruation at the time of diagnosis by patientreport

  • Completed chemotherapy within the past year

  • Report cessation of menses during or after chemotherapy and have not experiencedmenses recovery at the time of enrollment.

  • Have been without menses for at least 3 months following the completion ofchemotherapy

  • Willing to adhere to all study-related procedures, including randomization to one ofthe two possible arms: acupuncture and WLC

Exclusion

Exclusion Criteria:

  • Metastatic cancer (stage IV)

  • Had been pregnant or lactating within 3 months prior to enrollment

  • History of hysterectomy or oophorectomy

  • Ongoing or planned radiation or surgery within 4 months from randomization

  • Use of acupuncture for menses recovery within 3 months of enrollment

  • Had been or will be receiving ovarian suppression medicine, such as leuprolide (Lupron) and goserelin (Zoladex), or hormonal contraception drugs within 3 months ofenrollment or during the study period

Study Design

Total Participants: 60
Treatment Group(s): 2
Primary Treatment: Acupuncture
Phase: 2
Study Start date:
March 31, 2025
Estimated Completion Date:
March 31, 2027

Connect with a study center

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities)

    Basking Ridge, New Jersey 07920
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Monmouth (All protocol activities)

    Middletown, New Jersey 07748
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Bergen (All Protocol Activities)

    Montvale, New Jersey 07645
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)

    Commack, New York 11725
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Westchester (All Protocol Activities)

    Harrison, New York 10604
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)

    New York, New York 10065
    United States

    Active - Recruiting

  • Memorial Sloan Kettering Nassau (All Protocol Activities)

    Rockville Centre, New York 11553
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.